SIGA Technologies Inc.

SIGANASDAQ • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
4.68 USD
↘ 0.08 (1.68%)AT CLOSE (11:59 AM EDT)
4.72
↗ 0.04 (0.77%)
POST MARKET (AS OF 05:54 PM EDT)
Post Market
AS OF 05:54 PM EDT
4.72
↗ 0.04 (0.77%)
🔴Market: CLOSED
Open?$4.76
High?$4.79
Low?$4.66
Prev. Close?$4.76
Volume?417.0K
Avg. Volume?498.2K
VWAP?$4.72
Rel. Volume?0.84x
Bid / Ask
Bid?$4.65 × 400
Ask?$4.77 × 100
Spread?$0.12
Midpoint?$4.71
Valuation & Ratios
Market Cap?335.7M
Shares Out?71.7M
Float?40.4M
Float %?56.4%
P/E Ratio?16.59
P/B Ratio?2.21
EPS?$0.28
Dividend?12.89%
Ex-Dividend?N/A

SIGA Technologies Inc. (SIGA) is currently trading at $4.68. Our models show a "Neutral" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9 and a bearish Death Cross on the long-term moving averages. On the valuation side, SIGA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of May 29, 2026.

News
Profile
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesDefense & National Security›Defense Supply Chain & Components
Employees
49
Market Cap
341.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.siga.com
Listed
1997-09-09
Address
31 EAST 62ND STREET
NEW YORK, NY 10065
Phone: 212-672-9100
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
91
Momentum?
75
Short Sent.?
34
Piotroski F-Score?1/9Weak
Altman Z-Score?3.93Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.20%Elevated
Short Interest?3.3M
Days to Cover?6.1
Free Float40.4M
Avg Daily Volume541.9K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.25Strong
Quick Ratio?2.38Strong
Cash Ratio?2.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
94/100
P/E?
Peers
100
S&P
76
16.6CHEAP▾
P/B?
Peers
100
S&P
70
2.21CHEAP▾
P/S?
Peers
100
S&P
43
3.58FAIR▾
P/FCF?
Peers
100
S&P
82
12.2CHEAP▾
EV/EBITDA?
Peers
100
S&P
86
9.0CHEAP▾
EV/Sales?
Peers
100
S&P
74
2.03CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
49
13.3%STRONG▾
ROA?
Peers
50
S&P
71
9.2%STRONG▾
Cash Flow & Enterprise
FCF?$27.4M
Enterprise Value?$190.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist